Based on the reference panel evaluation, tumors were considered positive for FRα expression when ≥75% of tumor cells demonstrated moderate (2+) or strong (3+) membranous staining, including circumferential, apical, and dot-like patterns (Figure 1) [19,20]. The gene discussed is FOLR1; the disease is neoplasm.